|
1
|
Network CGAR, . Cancer Genome Atlas
Research Network: Comprehensive molecular characterization of
gastric adenocarcinoma. Nature. 513:202–209. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gupta GP and Massagué J: Cancer
metastasis: Building a framework. Cell. 127:679–695. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Takaishi S, Okumura T, Tu S, Wang SS,
Shibata W, Vigneshwaran R, Gordon SA, Shimada Y and Wang TC:
Identification of gastric cancer stem cells using the cell surface
marker CD44. Stem Cells. 27:1006–1020. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Takaishi S, Okumura T and Wang TC: Gastric
cancer stem cells. J Clin Oncol. 26:2876–2882. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kas K, Finger E, Grall F, Gu X, Akbarali
Y, Boltax J, Weiss A, Oettgen P, Kapeller R and Libermann TA:
ESE-3, a novel member of an epithelium-specific ets transcription
factor subfamily, demonstrates different target gene specificity
from ESE-1. J Biol Chem. 275:2986–2998. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Albino D, Longoni N, Curti L, Mello-Grand
M, Pinton S, Civenni G, Thalmann G, D'Ambrosio G, Sarti M, Sessa F,
et al: ESE3/EHF controls epithelial cell differentiation and its
loss leads to prostate tumors with mesenchymal and stem-like
features. Cancer Res. 72:2889–2900. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Stephens DN, Klein RH, Salmans ML, Gordon
W, Ho H and Andersen B: The Ets transcription factor EHF as a
regulator of cornea epithelial cell identity. J Biol Chem.
288:34304–34324. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tugores A, Le J, Sorokina I, Snijders AJ,
Duyao M, Reddy PS, Carlee L, Ronshaugen M, Mushegian A, Watanaskul
T, et al: The epithelium-specific ETS protein EHF/ESE-3 is a
context-dependent transcriptional repressor downstream of MAPK
signaling cascades. J Biol Chem. 276:20397–20406. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Brenne K, Nymoen DA, Hetland TE, Trope' CG
and Davidson B: Expression of the Ets transcription factor EHF in
serous ovarian carcinoma effusions is a marker of poor survival.
Hum Pathol. 43:496–505. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shi J, Qu Y, Li X, Sui F, Yao D, Yang Q,
Shi B, Ji M and Hou P: Increased expression of EHF via gene
amplification contributes to the activation of HER family signaling
and associates with poor survival in gastric cancer. Cell Death
Dis. 7:e24422016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lee RC, Feinbaum RL and Ambros V: The
C. elegans heterochronic gene lin-4 encodes small RNAs with
antisense complementarity to lin-14. Cell. 75:843–854. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Reinhart BJ, Slack FJ, Basson M,
Pasquinelli AE, Bettinger JC, Rougvie AE, Horvitz HR and Ruvkun G:
The 21-nucleotide let-7 RNA regulates developmental timing in
Caenorhabditis elegans. Nature. 403:901–906. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Farh KK-H, Grimson A, Jan C, Lewis BP,
Johnston WK, Lim LP, Burge CB and Bartel DP: The widespread impact
of mammalian MicroRNAs on mRNA repression and evolution. Science.
310:1817–1821. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
He L, Thomson JM, Hemann MT,
Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe
SW, Hannon GJ, et al: A microRNA polycistron as a potential human
oncogene. Nature. 435:828–833. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Johnson SM, Grosshans H, Shingara J, Byrom
M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D and Slack
FJ: RAS is regulated by the let-7 microRNA family. Cell.
120:635–647. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Roldo C, Missiaglia E, Hagan JP, Falconi
M, Capelli P, Bersani S, Calin GA, Volinia S, Liu CG, Scarpa A, et
al: MicroRNA expression abnormalities in pancreatic endocrine and
acinar tumors are associated with distinctive pathologic features
and clinical behavior. J Clin Oncol. 24:4677–4684. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zheng Z, Yan D, Chen X, Huang H, Chen K,
Li G, Zhou L, Zheng D, Tu L and Dong XD: MicroRNA-206: Effective
Inhibition of Gastric Cancer Progression through the c-Met Pathway.
PLoS One. 10:e01287512015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang L, Xia L, Zhao L, Chen Z, Shang X,
Xin J, Liu M, Guo X, Wu K, Pan Y, et al: Activation of PAX3-MET
pathways due to miR-206 loss promotes gastric cancer metastasis.
Carcinogenesis. 36:390–399. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liao XH, Li YQ, Wang N, Zheng L, Xing WJ,
Zhao DW, Yan TB, Wang Y, Liu LY, Sun XG, et al: Re-expression and
epigenetic modification of maspin induced apoptosis in MCF-7 cells
mediated by myocardin. Cell Signal. 26:1335–1346. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liao XH, Wang Y, Wang N, Yan TB, Xing WJ,
Zheng L, Zhao DW, Li YQ, Liu LY, Sun XG, et al: Human chorionic
gonadotropin decreases human breast cancer cell proliferation and
promotes differentiation. IUBMB Life. 66:352–360. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liao XH, Xiang Y, Yu CX, Li JP, Li H, Nie
Q, Hu P, Zhou J and Zhang TC: STAT3 is required for
miR-17-5p-mediated sensitization to chemotherapy-induced apoptosis
in breast cancer cells. Oncotarget. 8:15763–15774. 2017.PubMed/NCBI
|
|
27
|
Liao XH, Li JY, Dong XM, Wang X, Xiang Y,
Li H, Yu CX, Li JP, Yuan BY, Zhou J, et al: ERα inhibited
myocardin-induced differentiation in uterine fibroids. Exp Cell
Res. 350:73–82. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liao XH, Lu DL, Wang N, Liu LY, Wang Y, Li
YQ, Yan TB, Sun XG, Hu P and Zhang TC: Estrogen receptor α mediates
proliferation of breast cancer MCF-7 cells via a
p21/PCNA/E2F1-dependent pathway. FEBS J. 281:927–942. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xiang Y, Lu DL, Li JP, Yu CX, Zheng DL,
Huang X, Wang ZY, Hu P, Liao XH and Zhang TC: Myocardin inhibits
estrogen receptor alpha-mediated proliferation of human breast
cancer MCF-7 cells via regulating MicroRNA expression. IUBMB Life.
68:477–487. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kondo N, Toyama T, Sugiura H, Fujii Y and
Yamashita H: miR-206 Expression is down-regulated in estrogen
receptor α-positive human breast cancer. Cancer Res. 68:5004–5008.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ren Z-G, Dong S-X, Han P and Qi J: miR-203
promotes proliferation, migration and invasion by degrading SIK1 in
pancreatic cancer. Oncol Rep. 35:1365–1374. 2016.PubMed/NCBI
|
|
32
|
Pasquinelli AE, Reinhart BJ, Slack F,
Martindale MQ, Kuroda MI, Maller B, Hayward DC, Ball EE, Degnan B,
Müller P, et al: Conservation of the sequence and temporal
expression of let-7 heterochronic regulatory RNA. Nature.
408:86–89. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wakamatsu Y, Sakamoto N, Oo HZ, Naito Y,
Uraoka N, Anami K, Sentani K, Oue N and Yasui W: Expression of
cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and
lymph node metastasis of gastric cancer. Pathol Int. 62:112–119.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kong D, Banerjee S, Ahmad A, Li Y, Wang Z,
Sethi S and Sarkar FH: Epithelial to mesenchymal transition is
mechanistically linked with stem cell signatures in prostate cancer
cells. PLoS One. 5:e124452010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shidal C, Al-Rayyan N, Yaddanapudi K and
Davis KR: Lunasin is a novel therapeutic agent for targeting
melanoma cancer stem cells. Oncotarget. 7:84128–84141.
2016.PubMed/NCBI
|
|
36
|
Gao Y, Liu T, Cheng W and Wang H:
Isolation and characterization of proliferative, migratory and
multidrug-resistant endometrial carcinoma-initiating cells from
human type II endometrial carcinoma cell lines. Oncol Rep.
28:527–532. 2012.PubMed/NCBI
|
|
37
|
Dean M, Fojo T and Bates S: Tumour stem
cells and drug resistance. Nat Rev Cancer. 5:275–284. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Xu ZY, Tang JN, Xie HX, Du YA, Huang L, Yu
PF and Cheng XD: 5-Fluorouracil chemotherapy of gastric cancer
generates residual cells with properties of cancer stem cells. Int
J Biol Sci. 11:284–294. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang L, Liu X, Jin H, Guo X, Xia L, Chen
Z, Bai M, Liu J, Shang X, Wu K, et al: miR-206 inhibits gastric
cancer proliferation in part by repressing cyclinD2. Cancer Lett.
332:94–101. 2013. View Article : Google Scholar : PubMed/NCBI
|
